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Unraveling the molecular basis of inherited disorders
of epithelial fragility has led to understanding of the
complex structure and function of keratin intermedi-
ate ®laments. Keratins are organized as a central a-
helical rod domain ¯anked by nonhelical, variable
end domains. Pathogenic mutations in 19 different
keratin genes have been identi®ed in sequences cor-
responding to conserved regions at the beginning
and end of the rod. These areas have been recog-
nized as zones of overlap between aligned keratin
proteins and are thought to be crucial for proper
assembly of keratin intermediate ®laments.
Consequently, all keratin disorders of skin, hair, nail,
and mucous membranes caused by mutations in rod
domain sequences are characterized by perinuclear
clumping of fragmented keratin intermediate ®la-
ments, thus compromising mechanical strength and
cell integrity. We report here the ®rst mutation in a
keratin gene (KRT1) that affects the variable tail
domain (V2) and results in a profoundly different
abnormality of the cytoskeletal architecture leading
to a severe form of epidermal hyperkeratosis known
as ichthyosis hystrix Curth±Macklin. Structural
analyses disclosed a failure in keratin intermediate
®lament bundling, retraction of the cytoskeleton
from the nucleus, and failed translocation of loricrin
to the desmosomal plaques. These data provide
the ®rst in vivo evidence for the crucial role of a
keratin tail domain in supramolecular keratin inter-
mediate ®lament organization and barrier formation.
Key words: corni®ed cell envelope/desmosomes/keratin
intermediate ®laments/loricrin/palmoplantar keratoderma. J
Invest Dermatol 116:511±519, 2001
I
chthyosis hystrix is a descriptive name for a clinically and
genetically heterogeneous group of skin disorders with
massive, spiky, or verrucous hyperkeratosis. The best-
known example is probably the ``porcupine men'' of the
Lambert family from Suffolk, England (Penrose and Stern,
1957). Some of the historically categorized types have now been
recognized as forms of epidermolytic hyperkeratosis (OMIM
113800), an autosomal dominant hyperkeratotic and blistering skin
disorder caused by mutations in the coexpressed keratin genes
KRT1 and KRT10 (Irvine and McLean, 1999). In contrast, a
distinct type of ichthyosis hystrix termed ichthyosis hystrix of
Curth±Macklin (IHCM, OMIM 146590) displays no skin fragility.
This rare disorder is characterized by peculiar ultrastructural
abnormalities of the cytoskeleton of differentiating keratinocytes.
In IHCM, KIF aggregate into continuous, peripheral shells, which
are often associated with perinuclear vacuolization and formation of
bi-nucleated cells, without signs of epidermolysis or keratin
clumping typical for epidermolytic hyperkeratosis (Kanerva et al,
1984; Anton-Lamprecht, 1994). Two large families with autosomal
dominant inheritance and several sporadic cases of IHCM have
been reported since its ®rst description in 1954 (Ollendorff Curth,
1954; Ollendorff-Curth et al, 1972; Kanerva et al, 1984; Niemi et al,
1990). Clinical expression varies even within families, and ranges
from palmoplantar keratoderma (PPK) to generalized skin
involvement.
In this study, we elucidated the genetic defect causing IHCM,
and identi®ed the ®rst reported mutation in a keratin end domain.
Our data suggest a critical function for the keratin 1 (K1) tail
domain during epidermal differentiation.
MATERIALS AND METHODS
Patients and biologic material We ascertained and examined a three-
generation African-American family (pedigree in Fig 1b) from Lubbock,
TX, including ®ve affected and three unaffected individuals. The clinical
diagnosis of autosomal dominant IHCM was based on dermatologic
examination (KN and GR), and histopathologic and electron
microscopic features. All participants gave their informed consent.
Peripheral blood samples or buccal swabs of all participants were
collected and prepared for DNA analysis following standard procedures.
Microsatellite marker analysis We analyzed in all family members 20
polymorphic microsatellite markers spanning four genomic regions. The
markers were derived from the GDB (http://gdbhttp://www.gdb.org),
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and included: D1S252, D1S498, D1S2346, D1S305, D1S484 (1q21);
D12S345, D12S270, D12S1622, D12S90, D12S326 (12q11±q13);
D17S933, D17S800, D17S934, D17S1868 (17q21); D18S877, D18S463,
D18S56, D18S1102, D18S1145, and D18S474 (18q12). Polymerase
chain reaction (PCR) ampli®cation from gDNA was performed using
¯uorescently labeled (6-FAM, HEX, NED phosphoramidite) and tailed
primers under standard conditions using Ampli Taq Gold (PE Applied
Biosystems, Foster City, CA). The PCR products were separated by
polyacrylamide gel electrophoresis on an ABI Prism 377 sequencer, and
genotypes were established using the GeneScan 3.1 and GenoTyper 2.0
software (PE Biosystems). Genotypes were used to construct
parsimonious haplotypes of all family members for each region.
Multipoint LOD score analysis was performed with GENEHUNTER
(Kruglyak et al, 1996) using the following marker map: D12S270±
2.19 cM±D12S1622±1.78 cM±D12S90. Allele frequencies were obtained
from the GDB database. The disorder was modeled as autosomal
dominant with complete penetrance and a disease allele frequency of
0.0001.
Mutation analysis KRT6a and KRT6b were ampli®ed from cDNA to
avoid ampli®cation of other KRT6 isoforms and pseudogenes. Total
RNA was extracted from a skin biopsy from affected individual 2
(Fig 1b) using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was
reverse transcribed and ampli®ed by PCR using the Titan One-Tube
reverse transcription±PCR System (Boehringer Mannheim, Indianapolis,
IN) and gene speci®c primer pairs as previously described (Smith et al,
1998, 1999). KRT1 was PCR ampli®ed from genomic DNA with Taq
polymerase and Q solution (Qiagen) using nine primer pairs spanning
the complete coding sequence and intron boundaries (Chipev et al,
1992). Cycling conditions were 95°C 5 min followed by 35 cycles at
95°C 30 s, 60°C 45 s, 72°C 90 s; and a ®nal extension step at 72°C for
7 min. After puri®cation with QIAquick gel extraction kit, PCR
fragments were directly sequenced using the BigDye terminator
sequencing system on an ABI Prism 377 sequencer (PE Applied
Biosystems). Sequence alterations were con®rmed by bidirectional
sequencing and subcloning of the ampli®ed alleles in a pGEM-T Easy
vector (Promega, Madison, WI) followed by direct sequencing using
KRT1 primers 5¢-GTC TCC AAG ATG GTG AAG CGG GGA ATG-
GGG AAG CG-3¢ (nt 4889±4923) and 5¢-CGG TAA GGC TGG-
GAC AAA TCG ACC TCG GTC TTG CC-3¢ (nt 5578±5612) (Chipev
et al, 1992). Allele-speci®c PCR ampli®cation with primers 5¢-GTC-
TCC AAG ATG GTG AAG CGG GGA ATG GGG AAG CG-3¢ (nt
4889±4923), 5¢-ACC TCC AGA ACC ATA GCT ATA-3¢ (nt 5190±
5211) (reverse, mutant allele) and 5¢-ACC TCC AGA ACC ATA GCT
ACC (nt 5191±5211) (reverse, wild-type allele) was used to assess
segregation of the mutation in the family and screen control samples.
Cycling conditions were 95°C 5 min followed by 35 cycles at 95°C
30 s, 57°C 45 s, 72°C 90 s; and a ®nal extension step at 72°C for 7 min.
Mass spectroscopic analysis Keratins were extracted from a scale
sample of an affected patient with a buffer of 0.125 M Tris±HCl
(pH 8.0) containing 1% sodium dodecyl sulfate (SDS) and 5% 2-
mercaptoethanol for 3 h at 23°C. The extract supernatant was made to
pH 6.8 and 10% glycerol, and resolved on 8% slab SDS gels. The desired
band of K1 was excised, crushed, extracted with 100 ml 50% acetonitrile
in 25 mM NH4HCO3 and dried under vacuum. The gel pieces were
Figure 1. Mutation analysis of the IHCM
family. (a) In affected individual 2, sequence
analysis of subcloned PCR fragments discloses a
GG to A substitution at nucleotide position 5191/
5192 (arrow) in exon 9 of KRT1 (right panel)
compared with the wild-type sequence (left panel).
This mutation leads to a frameshift and premature
translation termination. (b) Allele-speci®c PCR
ampli®cation reveals complete cosegregation of
the GG5191®A mutation with IHCM in this
family. In unaffected individuals, a 305 bp PCR
fragment is obtained only with a primer pair
speci®c for the wild-type sequence (WT), but not
with a primer pair speci®c for the mutant
sequence (MUT). Amplicons for both primer
pairs are detected in affected individuals,
indicating the presence of the mutation in one
allele of KRT1. Filled symbols in the pedigree
represent affected individuals. The proband 2 is
indicated by an arrow. (c) Comparison of the
amino acid sequence of wild-type (black) and
mutant (red, underlined) K1 spanning the V2
domain. Numbers denote the amino acid
positions. The region affected by the mutation is
indicated in the schematic drawing of K1.
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rehydrated in 40 ml of 25 mM NH4HCO3 (pH 8.1) containing 5%
acetonitrile and 0.01% SDS, as well as 20 mg per ml trypsin (sequencing
grade, Sigma, St Louis, MO) and 50 mg per ml of endoproteinase Glu-
C (Boehringer Mannheim, Indianapolis, IN). After digestion for 16 h at
30°C, peptides were extracted with 60% acetonitrile, 0.1% tri¯uoroacetic
acid, and then concentrated to 4±6 ml. Aliquots (1 ml) were spotted on
to nitrocellulose-coated sample stages, as described by Arnot et al (1998).
Spectra were acquired on a Voyager DE-PRO MALDI-TOF mass
spectrometer at an accelerating voltage of 20 kV, delay time of 100 ns,
re¯ector voltage of 75%. Scans (64±128) from a N2 laser (337 nm) were
averaged in each recorded spectrum. Identi®cation of proteins was done
online by the program ProFound (http://www.proteometrics.com).
Protein modeling The 3D structure of the ®rst 66 residues of the V2
domain of the wild-type K1 was modeled using the CHARMM
molecular mechanics package (Brooks et al, 1993) and the CHARMM
force ®eld (MacKerell et al, 1998). The initial conformation was set as an
extended conformation. Five distance constraints were used to direct the
molecule towards a likely conformation (Arg5±Tyr12, Tyr19±Tyr26,
Tyr26±Arg36, Tyr39±Tyr46, Tyr53±His60, residues numbered starting at
the beginning of the V2 domain at codon 514 of K1) during a 20 ps
molecular dynamics simulation at 500 K in vacuum. This simulation was
followed by 50 ps of molecular dynamics at 300 K with explicit water
molecules and without the initial distance constraints.
To model the 3D structure of the mutated V2 region of K1 (residues
514-stop codon 613), we ®rst performed secondary structure predictions
using the program PHDsec (Rost and Sander, 1993). The program
indicated three a-helical regions (residues 544±556, 564±578, and 589±
607), which were manually packed against each other to form a three-
helical bundle. Each helix was oriented so that the glutamic acid residues
face away from the bundle's core towards the surrounding water.
Relative tilt angles between the helices were set at approximately 30°.
The loop regions between the helices were initially set to a random loop
conformation. Using the CHARMM program and force®eld, the model
was minimized for 2000 steepest descent steps followed by 20 ps of
molecular dynamics at 500 K in vacuum. This simulation was followed
by 50 ps of molecular dynamics at 300 K with explicit water molecules.
Electron and immunoelectron microscopy Transmission electron
microscopy was performed as described elsewhere (Ishida-Yamamoto et
al, 1996). For immunoelectron microscopy, skin tissue samples were
cryo®xed, cryosubstituted and embedded in Lowicryl K11M resin
(Chemische Werke Lowi, Waldkraiburg, Germany). Ultrathin sections
were cut, collected on formvar-coated nickel grids, and immunostained
using antibodies against human keratins (pan-keratin, Nichirey, Tokyo,
Japan; DEK10 that recognizes K10, Dako, Glostrup, Denmark; and 34b
B4 that recognizes K1, although the exact epitope is unknown, Enzo
Diagnostics, New York, NY); as well as antibodies against human
loricrin (Babco, Richmond, CA). Ten nanometers of gold-conjugated
goat anti-rabbit or mouse IgG (Amersham, Buckinghamshire, U.K.)
were used as labels (Hainfeld, 1987). For quantitative evaluations, the
number of gold particles per 5 mm plasma membrane of upper granular
cells were counted on 10 randomly chosen immunoelectron microscopy
pictures (3 25,000) of a control skin sample and the patient's skin
sample. Only intracellular gold particles localized within 40 nm distance
from the plasma membrane were counted, considering that the thickness
of the corni®ed cell envelope is about 15±20 nm, gold particles are
10 nm in diameter and the antibody molecule is about 15 nm in
diameter (Ishida-Yamamoto et al, 1996). For each sample, the ratio of
numbers of gold particles over the desmosomal areas v the total number
of gold particles was calculated and tested for signi®cance using the
Student's t test.
Immunohistochemistry Five micrometer thick paraf®n-embedded
sections of skin biopsy samples (left shoulder, left knee) were
deparaf®nized, treated with 0.3% H2O2 for 30 min and incubated at
98°C for 30 min in an antigen retrieval solution (Dako, Carpinteria,
CA). The sections were then sequentially incubated with a primary
antibody and a secondary biotinylated antibody for 60 min each, an
avidin±biotinylated horseradish peroxidase complex (Vector Laboratories,
Burlingame, CA) for 30 min and 3-amino-9-ethylcarbazole in an H2O2
buffer (Biogenex, San Ramon, CA) for up to 3 min. We used rabbit
polyclonal antibodies against pro®laggrin (Zymed, San Francisco, CA),
loricrin, and cytokeratin 5 (Babco) as well as mouse monoclonal
antibodies against cytokeratins 1 and 6 (Novocastra Laboratories,
Newcastle upon Tyne, U.K.), cytokeratin 10/13 (Zymed), and
involucrin (Research Diagnostics Inc., Flanders, NJ). The secondary
antibodies were biotinylated anti-rabbit IgG or anti-mouse goat serums
(Vector Laboratories).
In vitro keratin intermediate ®lament assembly A full-length clone
of human keratin 10 (K10) (Chipev et al, 1996) was recon®gured into
the pET11a bacterial expression vector. To generate a mutant form
closely similar to the mutant K1 reported in this study, a single
nucleotide (T) was deleted from codon 461, and a guanine nucleotide of
codon 549 was mutated to adenosine by site-directed mutagenesis of the
expression vector (Wu et al, 2000). These molecular changes resulted in
a truncated C-terminus of K10 with a V2 tail consisting of 88 residues,
52 (59%) of which were alanine residues. The mutant and wild-type
K10 proteins were expressed in bacteria, inclusion bodies were prepared,
dissolved in SDS sample buffer, and the desired K10 bands were cut out
from 3 mm thick slab gels (Wu et al, 2000). Wild-type K1 was extracted
from normal human foreskin epidermis and recovered the same way.
Molar mixtures of 1:1 wild-type K1 and K10 or 1:0.5:0.5 of wild-type
K1, wild-type K10, and mutant K10 (0.3 mg protein per ml) were
assembled in vitro into keratin intermediate ®laments as described, and
examined by electron microscopy (Wu et al, 2000).
RESULTS
Severe, mutilating palmoplantar keratoderma in a family
with IHCM We ascertained an African-American family, in
which ®ve members in three successive generations developed a
mutilating form of PPK. The diagnosis of IHCM was established by
Figure 2. Clinical spectrum of IHCM with
mutilating PPK. (a) Well-demarcated, yellow,
hyperkeratotic plaques extending in a striate
pattern over the ¯exural side of ®ngers and palm
of patient 4 in Fig 1 (age 31 y). (b) Massive
palmar keratoderma of the left hand of individual
2 (age 56 y) accompanied by hand contractures
and deep ®ssures of the skin. (c) Well-demarcated
hyperkeratotic plaques with cobblestone-like
surface over the knees of individual 9 (age 5 y).
(d) Hyperkeratosis of the soles in individual 2.
The plantar surface is covered by horny, rigid
spikes. Note amputation of all toes (left foot) and
fourth and ®fth toes (right foot) due to
pseudoainhum and secondary infections. (e) Small,
coalescent, ¯at-topped hyperkeratotic papules
covering almost the entire surface of the upper
back of individual 2. (f) Star®sh-like hyperkeratosis
over the knuckle of individual 4. (g) A skin biopsy
of individual 2 (shoulder) discloses orthokeratotic
hyperkeratosis, hypergranulosis, acanthosis, and
church spire-like papillomatosis (haematoxylin±
eosin, scale bar: 90 mm). The arrow indicates a bi-
nucleated cell in the granular layers.
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dermatologic examination of all family members and electron
microscopic examination of skin biopsies of affected individual 2
(Fig 1). Affected family members had severe, sharply demarcated
PPK with a verrucous surface (Fig 2, Table I). The lesions
followed a striate pattern on the palmar surface of the hands, but
were diffusely distributed on the soles. The PPK was complicated
by painful, deep ®ssures, bleeding, ¯exural contractures and edema
of the digits. Circular constriction bands (pseudoainhum) and
secondary bacterial infections necessitated toe amputations in two
family members (Table I). Massive hyperkeratosis of the soles
produced hard, horny, overlapping excrescencies up to 3 cm thick,
which compromised ambulation. In addition, star®sh-like
hyperkeratoses, knuckle pads, hyperkeratotic plaques with a
cobblestone-like surface over the joints and in large skin folds,
and in one individual, coalescent ¯at papules on the back were
noted (Fig 2, Table I); however, there was no evidence for
blistering, peeling or increased fragility of the skin or any other
organ manifestations.
Light and electron microscopical examination (Figs 2 and 3) of
skin biopsies from the shoulder and sole of individual 2 revealed
similar pathologic features, including hyperkeratosis, hypergranu-
losis, acanthosis, and papillomatosis, which were more pronounced
in the sole skin. In addition, we observed a small number of bi-
nucleated cells, perinuclear vacuolization and abnormal cytoplasmic
organization of KIF restricted to spinous and granular cells, which
are hallmarks of IHCM. KIF of normal diameter (10 nm) were not
radially arranged in densely packed bundles as normally seen.
Instead, they formed a shell-like, interspersed network that was
attached to the desmosomes at the plasma membrane but retracted
from the nuclear envelope leaving a clear halo around the nucleus.
The conspicuous shells were immunoreactive with antibodies
directed against K1 and K10, demonstrating that the ®laments are
composed of type I and II keratins (Fig 3). Overall, these structural
abnormalities were indicative of a failure of cytoplasmic KIF
packaging in differentiating keratinocytes.
A heterozygous frameshift mutation in KRT1 causes
IHCM The distinct ultrastructural abnormalities of IHCM
suggested an underlying defect in a keratin or KIF associated
protein. Therefore, we assessed in our family linkage of IHCM to
the epidermal differentiation complex on 1q21, the keratin gene
clusters on 12q11±q13 and 17q12±q21, and the desmosomal gene
cluster on 18q12. Our linkage results excluded the candidate
regions on 1q, 17q, and 18q (data not shown). In contrast, three
polymorphic and fully informative markers distributed across the
type II keratin cluster revealed complete cosegregation with the
disease in the IHCM family with a maximum multipoint LOD
score of 1.5 at locus D12S1622, which is supportive of linkage.
Affected members of the family shared a common disease-
associated haplotype across 18 cM in 12q.
Subsequent mutation analysis included several type II keratin
genes known to be expressed in differentiating keratinocytes and
implicated in disorders of corni®cation, KRT6a, KRT6b (pachyo-
nychia congenita), and KRT1 (epidermolytic hyperkeratosis,
nonepidermolytic PPK) (Irvine and McLean, 1999). Using
cDNA reverse transcribed from mRNA extracted from a skin
biopsy sample of affected individual 2 (Fig 1b), we excluded a
pathogenic mutation in the entire coding sequences of KRT6a and
KRT6b by direct DNA sequencing. The mutational hotspot
regions of KRT1 were also unremarkable. The patient, however,
carried two heterozygous sequence aberrations in exon 9, which
were present on the same allele of KRT1 as determined by
subcloning and sequence analysis of both KRT1 alleles. An in-
frame 21 bp deletion starting at position 5251 of the genomic
sequence (GenBank accession no. M98776) was recognized as a
common, previously described polymorphism leading to loss of a
glycine loop in the V2 domain of KRT1 (Korge et al, 1992a). The
second mutation was a substitution of two guanine bases for an
adenine base (5191GG®A) leading to a frameshift and premature
termination codon 229 bp downstream (Fig 1a). All ®ve affected
family members were found to be heterozygous for 5191GG®A
by sequence analysis, and allele-speci®c PCR ampli®cation veri®ed
the expected segregation of the mutation in the family (Fig 1b).
One hundred alleles of African-American and 100 alleles of
Caucasian unaffected, unrelated individuals did not carry this
mutation, excluding the possibility that it represents another
nonconsequential polymorphism. The mutation occurs in a
sequence encoding the V2 domain of K1 and is predicted to result
in frameshift and translation of an aberrant and truncated protein
tail of 77 residues, 32 residues shorter than the wild-type protein
(Fig 1c). This is the ®rst recognized pathogenic mutation affecting
the tail of a keratin molecule.
Identi®cation of the mutant K1 protein We assessed the
expression of the mutant K1 protein in the patient skin. K1 protein
was excised from a slab SDS±polyacrylamide gel electrophoresis
gel, subjected to proteolysis and then analyzed by MALDI-TOF
mass spectroscopy. As expected, the data (Fig 4) revealed many
tryptic peptides of K1. Two species of masses 1073.54 and 1453.83
atomic mass units did not correspond to any known protein in
public databases; however, these two exactly matched the masses of
two peptides that are part of the deduced sequence of the mutant
protein: V-A-A-A-A-M-A-A-T-A-P-E (residues 543±554) and
A-A-A-A-A-A-L-A-A-G-A-L-A-A-G-A-L-E (residues 567±584).
These data rigorously document the in vivo synthesis of an abnormal
K1 tail domain in IHCM.
The mutant V2 domain lacks the unique glycine-rich motifs
and ¯exible structure characteristic for wild-type K1 The
5191GG®A mutation is expected to have serious consequences for
the size, chemical character, and structure of the V2 domain of K1.
Normally, this region is almost exclusively composed of glycine and
hydrophilic residues (98.3%) interspaced by a small number of
hydrophobic residues (Fig 5a). These are likely to associate and
force the intervening glycine residues into a loop con®guration
(Steinert, 1993). On the contrary, the observed frameshift mutation
produces a polypeptide with quite different chemical characteristics
and a likely different three-dimensional conformation. As predicted
from the genomic sequence and con®rmed by mass spectroscopic
Table I. Clinical features of IHCM with mutilating PPK in a three-generation family
Individual
ID
















2 M 54 3 Striate Diffuse + + +/+ + +
4 F 34 1 Striate Diffuse + + +/+ +
5 F 33 2 Striate Diffuse + + ± /+ +
7 M 15 1 Striate Diffuse + +
9 M 4 6 mo Striate Diffuse + +
aAOO, age of onset.
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analysis, the structurally unique glycine residues are largely
eliminated and primarily replaced with alanine residues resulting
in a highly hydrophobic domain with 81% of nonpolar residues
(Fig 5a).
Using the CHARMM molecular mechanics software, we
generated a three-dimensional structural model of the ®rst half
(66 residues) of the polar V2 domain of wild-type K1. This
modeling predicts an extended, ``tentacle-like'', water-exposed
conformation (Fig 5b), rather than a rosette-like structure as earlier
proposed (Steinert, 1993). The V2 conformation may be stabilized
by a complex series of hydrogen bonds that break and reform
continuously producing an inherently ¯exible, twisting, and
dynamically transient structure, consistent with available nuclear
magnetic resonance data (Mack et al, 1988). In contrast, the
hydrophobic mutant V2 region is likely to acquire a compact
globular structure by forming a bundle of three a-helices (Fig 5c).
As a consequence, the mutant V2 is approximately two times
shorter than the wild-type domain, and has lost its ¯exibility and
ability to form intramolecular and intermolecular hydrogen bonds.
Such a dramatic change most likely precludes all normal inter-
actions of the V2 domain.
Cytoplasmic distribution of loricrin, a corni®ed cell
envelope protein, is disturbed by mutation 5191GG®A
Immunohistochemical analysis of affected skin tissue in IHCM
demonstrated decreased K1 staining but a typical distribution
pattern compared with normal skin (Fig 6a, b) and expression of
keratins K5 and K10 (data not shown); however, loricrin staining in
the granular layers was reduced, discontinuous and irregular.
Various amounts of loricrin were found in clumps, especially at the
bottom of the papillae, contrasting with the normal band-like,
regular staining pattern (Fig 6c, d). Other epidermal proteins
expressed during keratinocyte differentiation, including involucrin
and pro®laggrin, did not show abnormalities (data not shown).
These ®ndings suggest that mutation 5191GG®A results in an
abnormal protein that disturbs physiologic interactions between K1
and loricrin, and consequently, the corni®ed cell envelope
formation.
Subsequent immunoelectron microscopy revealed an aberrant
distribution of loricrin in granular keratinocytes, further corrobor-
ating this conclusion. In contrast with normal skin, loricrin did not
accumulate at the desmosomal attachment plaques (Ishida-
Yamamoto et al, 1996), but was found diffusely along the plasma
membrane with sparing of the desmosomal areas (Fig 7).
Morphometric analysis con®rmed a signi®cant (p < 0.001) decrease
in the number of gold particles located at the desmosomal
complexes (Fig 7e) as well as a signi®cant reduction in the ratio
of gold particles over desmosomal complexes to the total number of
scored gold particles in the patient skin sample (mean
0.30 6 0.013) compared with the control skin sample (mean
0.66 6 0.016; p < 0.0005).
Structural abnormalities of in vitro assembled KIF
containing a mutant K10 with a truncated, alanine-rich
tail domain similar to the bona ®de mutant K1 In vitro
experiments are desirable to determine the functional consequences
of the described KRT1 mutation on the protein level and the role
of V2 of K1, including its possible interaction with loricrin. These
studies, however, are hampered by the fact that we and others have
been unable to produce a full-length cDNA clone of K1,
presumably due to the extraordinarily high GC content of the
head and tail domain sequences that interfere with PCR reactions
needed to assemble a clone (Korge et al, 1992a). Furthermore,
loricrin is insoluble in the pH range at which KIF are stable in
solution (Candi et al, 1995). Therefore, we performed an in vitro
KIF assembly assay using wild-type K1 and mutant K10. In
terminally differentiating epidermal cells, K1 and K10 coassemble
into KIF. As K10 contains a glycine-rich V2 domain, which is
highly homologous to V2 of K1, we used a full-length clone of K10
(Chipev et al, 1996) instead of K1. We produced a truncated,
alanine-rich tail domain of K10 containing 88 residues and 59%
alanine very similar to the observed changes in the mutant K1. In
Figure 3. Electron microscopy reveals
abnormal organization of keratin
intermediate ®laments. Spinous cells in patient
(individual 2) sole skin (a, b) and normal control
sole skin (c, d). The areas marked with brackets in
a and c are shown in a higher magni®cation in b
and d, respectively. Keratin ®laments in the
patient's skin are of normal thickness (about
10 nm) and retain their connection with
desmosomes (D). They do not form thick bundles
as seen in normal control and are retracted from
the perinuclear zone leaving a clear space (*). N,
nuclei. Scale bars: (a, c) 1 mm; (b, d) 0.1 mm. (e)
Globular keratohyalin granules (k) are associated
with peripheral shells of tangled ®laments (*) in
the granular cells. Corni®ed cell envelopes (arrows)
are formed in the more differentiated granular
cells. Scale bar: 2 mm. (f, g) 34bB4 immuno-
electron microscopy of a spinous cell in the
patient's sole skin (f) and normal control sole skin
(g) shows that the abnormal ®laments (*) are
keratin-immunoreactive. 10 nm gold labeling.
Scale bars: 0.2 mm.
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vitro assembly of equimolar mixtures of wild-type K1 and K10
under optimal conditions resulted in the formation of regular KIF
of normal diameter with a smooth surface and > 2 mm long
(Fig 4b). In order to re¯ect the in vivo situation with one normal
and one abnormal allele, we evaluated in vitro ®lament formation in
a molar mixture containing 50% wild-type K1, 25% wild-type K10,
and 25% mutant K10. This yielded almost normal-appearing KIF of
> 2 mm length; however, the surface of these ®laments showed
irregularities and protrusions with a periodicity of 22±23 nm
(Fig 4c), which are likely to represent the end domains. End
domains are normally invisible by negative staining methods, and
appear only on shadowing (Steven et al, 1989). Thus the end
domains have become visible due to the changed nature and
organization of their V2 domain. Because the V2 domains of K1
and K10 are highly homologous, it is reasonable to conclude that
similar results would be expected for the mutant K1. Accordingly,
our data support the hypothesis that the alanine-rich mutant V2
domain does not impede KIF assembly, but rather interferes with
normal KIF function, including speci®cally their supramolecular
organization in cells and interactions with other cellular
constituents.
DISCUSSION
This study elucidates the molecular basis of IHCM, a rare,
autosomal dominant form of ichthyosis with severe hyperkeratosis,
and provides for the ®rst time in vivo evidence for the tissue-speci®c
functions of a keratin tail domain. The clinical and histologic
features of the skin disorder in our family had been previously
described as possibly Vohwinkel's mutilating PPK with ichthyosis
(Cole et al, 1984); however, many characteristics of this latter
disease, in particular diffuse PPK with a honeycomb surface, striate
hyperkeratotic lesions on the extremities, and retained nuclei in the
stratum corneum by light microscopic examination were not
observed. Our ultrastructural studies of lesional skin unveiled a
disturbed organization of the KIF network in the differentiating
layers of the epidermis with formation of cytoplasmic KIF shells,
which are the hallmark of IHCM. These results underscore once
again the value of structural and ultrastructural studies for the
diagnosis of different forms of ichthyoses and PPK with overlapping
clinical features.
We identi®ed a heterozygous mutation in exon 9 of KRT1 in a
family with IHCM. Interestingly, a previous report had excluded
IHCM from both keratin gene loci (Bonifas et al, 1993); however,
the phenotypic features of the family assessed in this study,
including localized hyperkeratotic plaques over the joints and
sparing of palms and soles, were milder and distinct from those
found in our family (Niemi et al, 1990; Bonifas et al, 1993). Thus,
genetic heterogeneity cannot be excluded in IHCM. The mutation
5191GG®A results in a frameshift, leading to the expression of a
K1 protein possessing a mutant variable tail domain (Figs 1 and 4).
The ensuing structural abnormalities in IHCM are distinctly
different from the phenotype of keratin mutations involving
conserved sequences of the a-helical rod domains (Irvine and
McLean, 1999). Whereas the latter mutations disturb proper keratin
oligomerization and ®lament assembly undermining the physical
resilience of cells, the mutation that we detected in the V2 domain
of K1 apparently does not inhibit KIF formation. Two mis-sense
mutations involving the nonhelical head (V1) domain of either K1
or K5 (Kimonis et al, 1994; Uttam et al, 1996), which are probably
Figure 4. Identi®cation of the mutant K1
protein in vivo. (a) MALDI-TOFF spectrum of
peptides obtained by double digestion with trypsin
and endoproteinase Glu-C. The two peptides of
mass 1073.54 and 1453.83 atomic mass units
exactly match peptides V-A-A-A-A-M-A-A-T-A-
P-E and A-A-A-A-A-A-L-A-A-G-A-L-A-A-G-
A-L-E of the aberrant K1 tail. (b, c) Transmission
electron microscopy of in vitro assembled K10
intermediate ®laments containing 50% wild-type
K1 and (b) 50% wild-type K10; or (c) 25% wild-
type K10 and 25% of mutant K10 with a
truncated and alanine-rich tail domain similar to
the described bona ®de K1 in IHCM. Note that
both preparations are of normal length and
diameter. Arrows in (c) indicate the abnormal
lateral protrusions along the length of ®laments,
which are observed with a periodicity of 22±
23 nm. Scale bars: 0.1 mm.
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caused by a failure of cross-linking KIF to proteins of the corni®ed
cell envelope (Steinert and Marekov, 1995) and desmoplakin
(Kouklis et al, 1994), also have differing phenotypic features but
show no keratin shell formation as seen in IHCM. Hence, the
nature and the speci®c location of keratin mutations are critical
determinants of their different clinical manifestation and pathobiol-
ogy.
The massive, spiky hyperkeratosis with hystrix-like appearance is
a distinct yet not unique feature of IHCM that has also been
observed in patients with epidermolytic hyperkeratosis or erythro-
keratodermia variabilis, although its pathomechanisms remain
elusive. We noticed that scales obtained from the palms and soles
of an affected individual contained considerably more keratins K6,
K16, and K17 than normal stratum corneum (data not shown).
These data could re¯ect a complementary and/or compensatory
overexpression of other epidermal keratins due to the impaired
function of K1 similar to the overexpression of K6/K16 observed
in K10 knockout mice (Reichelt et al, 1997). As the targeted
overexpression of human K16 in the epidermis and hair follicles of
transgenic mice interferes with the terminal differentiation of
keratinocytes and results in acanthosis and hyperkeratosis
(Takahashi et al, 1994), it is tempting to speculate that similar
mechanisms could contribute to the phenotype of IHCM.
The structure and intrinsic functions of nonhelical keratin end
domains are largely unknown. They greatly vary in sequence and
length, and are thus thought to determine keratin functional
speci®city (Parry and Steinert, 1995). In vitro assembly studies and
cell transfection experiments of intermediate ®laments with
truncated head and tail domains have demonstrated that V2 is not
necessary for intermediate ®lament oligomerization, assembly, and
alignment (Fuchs and Weber, 1994). Results of our in vitro
assembly assay using mutant K10 (with analogous changes of the V2
domain as in the observed mutant K1) further con®rm that the
assembly of KIF does not depend on the structural integrity of V2.
Although V2 might govern lateral KIF association at the
proto®lament and proto®bril level for some keratins (Fuchs and
Weber, 1994), it might be even dispensable to others as illustrated
by the near tail-less keratin 19 expressed in simple epithelia
(Fradette et al, 1998). The glycine-rich composition and repetitive
loop-structure of the V2 domains of K1 and its epidermal
expression partner K10 are exceptional and suggest that these tail
domains are prerequisite for the tissue-speci®c role of KIF in the
corni®cation process of the skin (Parry and Steinert, 1995).
Common polymorphisms that alter the size and number of these
glycine loops are apparently tolerable because they do not interfere
with the organization or function of these motifs (Korge et al,
1992a, b). The end-domain of the corni®ed cell envelope loricrin is
also characterized by recurrent glycine loop motifs. Our protein
modeling data indicate that the tentacle-like, ¯exible structure of
V2 might allow the glycine loops of keratins K1 and K10 to interact
directly with each other as well as with loricrin through weak
hydrophobic interactions and hydrogen bonding, supporting the
previously proposed ``Velcro hypothesis'' (Steinert, 1993).
The loss of such intrinsic functions of the V2 domain of K1 is
implied by the structural abnormalities that we observed in affected
skin tissue in IHCM. Although keratinocytes still express wild-type
K1, the cytosolic KIF organization in IHCM is profoundly
disturbed, suggesting that the mutant V2 dominantly interferes
with normal K1 function. The peculiar, shell-like accumulation of
interwoven KIF evident by electron microscopy (Fig 3) indicates a
failure of cytoplasmic KIF packaging in differentiating keratino-
cytes. Thus, traf®cking and higher order organization of KIF to
bundles inside epithelial cells is clearly impaired in IHCM. The
head and tail domains of the keratin chains are assumed to extend
from the surface of KIF by up to 4 nm (Steven et al, 1985), but are
too short to cross-bridge the average gap of at least 15 nm between
individual KIF in a tono®bril bundle. Based on our data, we
envision that the laterally protruding V2 domain of K1 intercon-
nect with a ``spacer'' molecule, which facilitates the parallel
alignment of KIF into tono®bril bundles and thus the supramo-
lecular organization of KIF in the cells. Such an arrangement would
be comparable with the proposed function of the long-tailed
intermediate ®lament nestin, which is thought to connect directly
vimentin or a-internexin with microtubules and micro®laments
(Herrmann and Aebi, 2000). The newly gained visibility of the
Figure 5. Protein prediction analysis of the wild-type and mutant
V2 domain of K1. Glycine is represented in yellow, polar residues in
red and apolar residues in green. (a) Polar/apolar analysis of V2 in K1
demonstrates the effect of the observed frameshift mutation, namely the
transformation of the V2 domain from a highly hydrophilic, glycine-rich
domain into a hydrophobic, glycine-poor region. For comparison, the
composition of the glycine-rich V1 region of K1 and end-domain of
loricrin are shown. (b) CHARMM protein modeling of the ®rst half of
the wild-type V2 domain of K1 showing an extended, ``tentacle-like'',
water-exposed conformation resulting from the presence of recurrent
glycine loops and a high percentage of hydrophilic residues. The whole
V2 domain is twice as long as depicted, and may adopt a more twisted
conformation. (c) CHARMM protein modeling of the mutant V2
domain. The break indicates the start of the aberrant tail. Based on a
standard secondary structure prediction (Rost and Sander, 1993), the
alanine-rich sequence of the mutant V2 is likely to form three a-helices.
The highly hydrophobic character of the mutant domain probably
generates a three-helical bundle structure to form a hydrophobic core.
Modeling data indicate that the mutant V2 tail is only half as long as the
wild-type domain because of compact globular packing and early
truncation of the mutant sequence. Only two of the 10 glycine loops
normally found in V2 are conserved.
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keratin end domains of in vitro assembled KIF containing an
aberrant tail on K10 (Fig 4c) demonstrate a serious alteration of the
normal structural organization of the tail domain. We suggest that
this may prohibit or interfere with normal functional interactions
with KIF and other proteins, thus leading to the observed disease
pathology.
In addition, the lack of a functional V2 domain of K1 evidently
deranged the distribution of loricrin in granular keratinocytes,
Figure 7. Aberrant plasma membrane
distribution of loricrin by immunoelectron
microscopy. Conventional electron microscopy
(a, b) and loricrin immunoelectron microscopy (c,
d) of granular keratinocytes of affected skin
(individual 2) (a, c) and normal control skin (b, d).
Continuous, band-like deposition of electron-
dense materials (arrowheads) is seen along the cell
membrane in the normal skin (b), but spares the
desmosomal plaques (D) in the affected skin (a).
Loricrin labels accumulate at the desmosomal
attachment plaques in normal skin (d, arrows), but
are mainly observed in the nondesmosomal areas
in the patient skin (c, arrowheads). Scale
bars: 0.2 mm. (e) The number of gold particles
counted over desmosomal areas was signi®cantly
lower in affected skin than in normal skin (p
< 0.001). The bars represent the total number of
scored gold labels 6 SEM in desmosomal and
interdesmosomal regions.
Figure 6. Immunostaining reveals reduced
K1 and abnormal distribution of loricrin.
Immunohistochemical staining of normal skin (a, c)
and affected skin (individual 2, shoulder) (b, d)
with antibodies raised against K1 (a, b) and
loricrin (c, d). Note the decreased intensity but
normal distribution of K1 in the cytoplasm of
suprabasal cells in the affected skin. In contrast,
loricrin staining pattern in the granular layers of
the affected epidermis is irregular and
discontinuous with frequent clumping at the
bottom of the papillae. Scale bar: 65 mm.
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whereas other differentiation-speci®c proteins without glycine loop
motifs were unaffected. We found loricrin diffusely distributed
along the cell membranes, but not preferentially associated with
desmosomes as normally seen. All known mutations in the loricrin
gene also destroy the glycine-rich repetitive motifs and result in
partially overlapping clinical features (Ishida-Yamamoto and Iizuka,
1998); however, the known loricrin mutations produce an
arginine-rich V2 tail, promoting aberrant translocation into the
nucleus and apparent interference with transcriptional activity, thus
representing a gain of function mechanism (Korge et al, 1997; Suga
et al, 2000). These observations are consistent with our hypothesis
that the glycine-rich sequences of K1 and K10 mediate, either
directly or indirectly, speci®c interactions between KIF and
loricrin. Therefore, it is tempting to speculate that the V2 domain
of K1 ``guides'' loricrin translocation perhaps by cohesive forces
between the shared tentacle-like domains, and consequently,
abnormal keratin±loricrin interactions disturb the accumulation of
loricrin at the cell periphery for the ®nal reinforcement stage of
corni®ed cell envelope assembly. Although this assumption
promotes a hitherto unrecognized mechanism explaining how
insoluble loricrin is translocated to the cell periphery, and supports
the theory that corni®ed cell envelope assembly is mostly an
energetically favored self-assembly process, further experimental
evidence is clearly needed.
In summary, we have elucidated the molecular basis of IHCM, a
severe disorder of corni®cation resulting from the disruption of the
V2 domain of K1. Our studies support two completely new
concepts of V2 function. We propose that V2 plays a pivotal part in
mediating the supramolecular organization of KIF and in directly or
indirectly facilitating the translocation of loricrin to the cell
periphery, where it initiates the ®nal reinforcement step during
corni®ed cell envelope formation.
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